Search Results - "MacGrogan G"

Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes.

Authors: Krupina, Ksenia Goginashvili, Alexander Baughn, Michael W. et al.

Source: Science. 12/11/2025, Vol. 390 Issue 6778, p1156-1163. 8p.

Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper.

Authors: Schaeffer, David F. Chan, Jennifer Morin, Jason et al.

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p347. 10p.

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Authors: Zerdes I Matikas A Mezheyeuski A et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Mar 07; Vol. 11 (1), pp. 23. Date of Electronic Publication: 2025 Mar 07.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism.

Authors: Boyer T Blaye C Chalopin D et al.

Source: Cell reports [Cell Rep] 2026 Jun 18; Vol. 45 (7), pp. 117568. Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial.

Authors: Blaye C Bidard FC Hue L et al.

Source: ESMO open [ESMO Open] 2026 Jun; Vol. 11 (6), pp. 107766. Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study.

Authors: Cazzaniga, Marina Elena Pronzato, Paolo Amoroso, Domenico et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1715. 12p.

Machine learning for predicting breast cancer risk and outcomes: a scoping review.

Authors: Alyani, Dini Gondhowiardjo, Soehartati

Source: Medical Journal of Indonesia. Jun2026, Vol. 35 Issue 2, p151-162. 12p.

Advances in Diagnostic, Prognostic and Predictive Biomarker Testing for the Characterization of Uterine Mesenchymal Neoplasms.

Authors: Dedda, Julia Zyla, Roman E.

Source: Onco. Jun2026, Vol. 6 Issue 2, p29. 30p.

Author index.

Source: Histopathology. Oct2008 Supplement, Vol. 53, p432-447. 16p.

Phase 1 Study of [¹⁷⁷Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.

Authors: Mittra, Erik S. Solnes, Lilja B. van der Veldt, Astrid A.M. et al.

Source: Journal of Nuclear Medicine. Feb2026, Vol. 67 Issue 2, p262-268. 7p.

Author Index for Volume 89.

Source: British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2355-2364. 10p.

Author Index for Volume 88.

Source: British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2342-2349. 8p.

Author index.

Source: Histopathology. Jun2003, Vol. 42 Issue 6, p626. 5p.

Cancer cells transfer invasive properties through microRNAs contained in collagen tracks.

Authors: Rouyer L Normand L Richard E et al.

Source: Cell reports [Cell Rep] 2025 Dec 23; Vol. 44 (12), pp. 116725. Date of Electronic Publication: 2025 Dec 10.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Impact of Neoadjuvant Chemotherapy Administration Time of Day on Pathological Response in Patients with Early Triple-Negative Breast Cancer.

Authors: Bouchez, Clémentine Catozzi, Simona Someil, Laetitia et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1299. 17p.

Basaloid‐Solid Adenoid Cystic Carcinoma of the Breast: A Case Report and Literature Review.

Authors: Zhou, Yijia Hu, Yun Zhang, Yansheng et al.

Source: Case Reports in Pathology. 3/3/2026, Vol. 2026, p1-5. 5p.

Heterogeneity of Hormone Receptors and HER2 in Breast Cancer Cutaneous Metastases: An Institutional Experience.

Authors: Iozzo, Roberta Belcastro, Eugenia Fanelli, Giuseppe Nicolò et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 5, p2377. 16p.

Imaging Ductal Carcinoma In Situ in the Era of De-Escalation: Role, Limits, and Clinical Implications for Risk-Adapted Management.

Authors: Buono, Marcella Schiavone, Luigi Rizzo, Sighelgaita et al.

Source: Diagnostics (2075-4418). Mar2026, Vol. 16 Issue 5, p776. 19p.

High-Risk Benign Breast Lesions: An Ontario Health (Cancer Care Ontario) Recommendations Report.

Authors: Eisen, Andrea Bane, Anita Causer, Petrina et al.

Source: Current Oncology. Feb2026, Vol. 31 Issue 2, p67. 21p.

Tailored therapies for triple-negative breast cancer: current landscape and future perceptions.

Authors: Khan Y Rizvi S Raza A et al.

Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Aug; Vol. 398 (8), pp. 9425-9450. Date of Electronic Publication: 2025 Mar 03.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE